Michael Morrissey Exelixis, Inc. (EXEL) insider trading activity

Michael Morrissey is President and CEO of EXELIXIS, INC.. Currently has a direct ownership of 1.42 Million shares of EXEL, which is worth approximately $59 Million. The most recent transaction as insider was on Feb 03, 2021, when has been sold 65,190 shares (Common Stock) at a price of $22.56 per share, resulting in proceeds of $1,470,686. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.42M

6.69% 3M change

92.24% 12M change

Total Value Held $59 Million

MICHAEL MORRISSEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2021	SELL Payment of exercise price or tax liability	$1,470,686 $22.56 p/Share	65,190 Reduced 10.28%	568,976 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	23,238 Added 5.37%	409,879 Common Stock
Nov 20 2020	SELL Bona fide gift	-	187,239 Reduced 32.63%	386,641 Common Stock
Nov 15 2020	SELL Payment of exercise price or tax liability	$503,073 $20.16 p/Share	24,954 Reduced 4.17%	573,880 Common Stock
Oct 22 2020	SELL Payment of exercise price or tax liability	$3,859,706 $21.79 p/Share	177,132 Reduced 22.83%	598,834 Common Stock
Oct 22 2020	BUY Grant, award, or other acquisition	-	672,861 Added 46.44%	775,966 Common Stock
Feb 03 2020	BUY Grant, award, or other acquisition	-	224,287 Added 26.13%	634,166 Common Stock

Also insider at

VERA

Vera Therapeutics, Inc. Healthcare